Browse by author
Lookup NU author(s): Professor Sir John BurnORCiD, Professor John Mathers
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Hereditary cancer due to pathological mutations in the mismatch repair gene family is now known as Lynch syndrome and affects at least 1 in 1,000 people, resulting in a 30-50% cancer risk most often involving the colorectum and endometrium. Annual or biennial colonoscopy reduces cancer deaths and many offer gynaecological surveillance, but most other associated cancers are not amenable to early detection. As microsatellite instability testing and tumour immunohistochemistry become routine, case finding will improve. Our recent demonstration that 600 mg aspirin per day for at least 2 years reduces the cancer burden by 63% after a 3-year lag period reinforces the need to identify gene carriers and introduce them to chemoprevention. CaPP3 will test different doses of aspirin in at least 3,000 gene carriers to determine whether low-dose aspirin is as effective. Copyright (c) 2012 S. Karger AG, Basel
Author(s): Burn J, Mathers J, Bishop DT
Publication type: Article
Publication status: Published
Journal: Digestive Diseases
Year: 2012
Volume: 30
Issue: s2
Pages: 39-47
Print publication date: 01/01/2012
ISSN (print): 0257-2753
ISSN (electronic): 1421-9875
Publisher: S. Karger AG
URL: http://dx.doi.org/10.1159/000341892
DOI: 10.1159/000341892
Altmetrics provided by Altmetric
